These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15359413)

  • 21. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.
    Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L
    Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-catenin and its regulatory network.
    Klymkowsky MW
    Hum Pathol; 2005 Mar; 36(3):225-7. PubMed ID: 15791565
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
    Zhang TF; Yu SQ; Guan LS; Wang ZY
    Anticancer Res; 2003; 23(5A):3575-84. PubMed ID: 14666652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence-based functional assay for Wnt/beta-catenin signaling activity.
    Zhou L; An N; Jiang W; Haydon R; Cheng H; Zhou Q; Breyer B; Feng T; He TC
    Biotechniques; 2002 Nov; 33(5):1126-8, 1130, 1132 passim. PubMed ID: 12449394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model reduction and analysis of robustness for the Wnt/beta-catenin signal transduction pathway.
    Krüger R; Heinrich R
    Genome Inform; 2004; 15(1):138-48. PubMed ID: 15712117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
    Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
    Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis.
    Sanders AJ; Ye L; Mason MD; Jiang WG
    Angiogenesis; 2010 Dec; 13(4):317-26. PubMed ID: 20848180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple oncogenic roles of nuclear beta-catenin.
    Kumar R; Bashyam MD
    J Biosci; 2017 Dec; 42(4):695-707. PubMed ID: 29229887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor.
    Yokoi A; McCrudden KW; Huang J; Kim ES; Soffer SZ; Frischer JS; Serur A; New T; Yuan J; Mansukhani M; O'Toole K; Yamashiro DJ; Kandel JJ
    Oncol Rep; 2003; 10(5):1271-4. PubMed ID: 12883692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes.
    Aoki M; Sobek V; Maslyar DJ; Hecht A; Vogt PK
    Oncogene; 2002 Oct; 21(46):6983-91. PubMed ID: 12370820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].
    Niu ZB; Wang CL; Hou Y; Yang Y; Gao H
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):461-4. PubMed ID: 17937859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of human cancer: pathogenesis and diagnosis. Keystone, Colorado, January 27-February 2, 1997.
    Kirsch IR
    Biochim Biophys Acta; 1997 Aug; 1333(1):R1-7. PubMed ID: 9294019
    [No Abstract]   [Full Text] [Related]  

  • 33. Smad4 transcriptional pathways and angiogenesis.
    Schwarte-Waldhoff I; Schmiegel W
    Int J Gastrointest Cancer; 2002; 31(1-3):47-59. PubMed ID: 12622415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of the Wnt signaling network in embryogenesis and tumorigenesis].
    Nakamura T; Akiyama T
    Seikagaku; 2005 Jan; 77(1):5-19. PubMed ID: 15770946
    [No Abstract]   [Full Text] [Related]  

  • 36. Wnt/beta-catenin--a canonical tale of cell-fate choice in the vertebrate skeleton.
    Kolpakova E; Olsen BR
    Dev Cell; 2005 May; 8(5):626-7. PubMed ID: 15866155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dysfunction of E-cadherin-catenin system in invasion and metastasis of colorectal cancer].
    Maruyama K; Ochiai A; Nakamura S; Baba S; Hirohashi S
    Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):402-8. PubMed ID: 9742518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Catenin: a pivot between cell adhesion and Wnt signalling.
    Bienz M
    Curr Biol; 2005 Jan; 15(2):R64-7. PubMed ID: 15668160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The integration of cell adhesion with gene expression: the role of beta-catenin.
    Ben-Ze'ev A; Shtutman M; Zhurinsky J
    Exp Cell Res; 2000 Nov; 261(1):75-82. PubMed ID: 11082277
    [No Abstract]   [Full Text] [Related]  

  • 40. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
    Kawauchi S; Liu XP; Kawasaki K; Hirakawa T; Amada S; Furuya T; Oga A; Sasaki K
    J Pathol; 2004 Nov; 204(3):268-76. PubMed ID: 15476271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.